|
|
| News of European HD Network |
- |
|
|
|
Pridopidine Dose Escalation Trial endorsed by EHDN.
At the meeting of the EC of EHDN on July 9, 2013 a Phase II dose escalation trial of pridopidine as proposed by Teva Pharmaceuticals was endorsed. Endorsement by the EC was preceded by a joint review of the HSG Scientific Review Committee and the Scientific and Bioethical Advisory Committee (SBAC) of EHDN.![[back]](/public/icons/back.gif)
|